G. S. Atwal

The paper analyzes SARS-CoV-2 genomic diversity to identify sites under selection, showing purifying selection dominates with some diversifying pressure, particularly in the spike protein and T cell epitopes.

This study shows that REGEN-COV, a combination of non-competing antibodies, provides broad coverage against SARS-CoV-2 variants and prevents the emergence of new variants in clinical and preclinical settings.

This study evaluates the efficacy of the REGN-COV2 antibody cocktail in preventing and treating SARS-CoV-2 infection in rhesus macaques and hamsters, showing reduced virus load and pathological effects.